Arbutus Biopharma Corp — insider transactions
5 transactions on record · ABUS · CIK 1447028
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
5
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
5
Bought, 3m
$0
Sold, 3m
$45.4M
Median disclosure lag
6.0 d
trade date to filing date
Largest single trade, 24m
$44.8M
2026-10-01
Director share, 12m
80.0%
of transactions where role is stated
Current run
5 sells
consecutive same-direction transactions
Net 3m flow
-$45.4M
purchases minus sales
Total on record
5
Transactions
5 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-07 | 2026-10-01 | 6 | Androski Lindsay | Director, President and CEO | Disposition to issuer | 24,655 | $5.00 | $123.3K | filing |
| 2026-10-07 | 2026-10-01 | 6 | Sawhney Roger | Director | Disposition to issuer | 17,142 | $5.00 | $85.7K | filing |
| 2026-10-07 | 2026-10-01 | 6 | Nguyen Tuan | Chief Financial Officer | Disposition to issuer | 48,081 | $5.00 | $240.4K | filing |
| 2026-10-07 | 2026-10-01 | 6 | Beardsley Robert A | Director | Disposition to issuer | 17,948 | $5.00 | $89.7K | filing |
| 2026-10-05 | 2026-10-01 | 4 | Roivant Sciences Ltd. | Director, 10% Owner | Disposition to issuer | 8,967,383 | $5.00 | $44.8M | filing |